Back to comparisons

Comparison

Phenylpiracetam vs Alpha-GPC

FieldPhenylpiracetamAlpha-GPC
Categoryracetamcholinergic
Dose range100–300mg300–600mg
Half-life4h6h
Onset30min30min
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●
Legal (US)USUnscheduledUSOTC
PubMed refs80320

The comparison in plain English

Auto-generated from data

Phenylpiracetam and Alpha-GPC are both in the racetam (racetam) and cholinergic respectively. Phenylpiracetam A phenylated derivative of piracetam 20-60x more potent. Alpha-GPC The most bioavailable common choline source.

Bottom line

Phenylpiracetam (evidence B, safety 4/5) has a stronger evidence base than Alpha-GPC (evidence A, safety 5/5). Alpha-GPC has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Phenylpiracetam if

Phenylpiracetam is the better fit when your goal aligns with its mechanism (Modulates AMPA, NMDA, and nicotinic acetylcholine receptors and increases dopamine receptor density (D1, D2, D3) in the striatum) and the dose range (100–300mg) suits your protocol. Half-life is 4h.

Choose Alpha-GPC if

Alpha-GPC is the better fit when your goal aligns with its mechanism (Rapidly absorbed and cleaved into choline and glycerophosphate) and the dose range (300–600mg) suits your protocol. Half-life is 6h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →